BUDESONIDE TEVA 3 mg, gastro-resistant capsule 50 tablets
Active ingredients: Budesonide
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant capsule50 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BUDESONIDE TEVA 3 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- 50 plaquettes prédécoupées unitaires PVC PVDC aluminium de 1 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Aug 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62029311CIP73025464CIP133400930254646Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BUDÉSONIDEgélule | 3 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.